drugset / Trial / NCT00190632

To Evaluate the Safety in Patients Taking Duloxetine for Stress Urinary Incontinence

NCT00190632

Phase 3 Completed 600 enrolled Eli Lilly and Company Boehringer Ingelheim · collab
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This is an on-going study to evaluate the long-term safety and maintenance of effect of duloxetine in patients suffering with stress urinary incontinence.

Timeline

Start
2001-03
Primary completion
Completion
2006-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule